Clinical Trials on Drug-induced Ototoxicity in Peritoneal Dialysis Patients in Canada
Total 10 results
-
St. Joseph's Healthcare HamiltonCanadian Institutes of Health Research (CIHR)RecruitingImproving Medication Prescribing-Related Outcomes for Vulnerable Elderly In Transitions (IMPROVE-IT)Drug-Related Side Effects and Adverse Reactions | Aged | Health Care Costs | Patient DischargeCanada
-
University Health Network, TorontoUnknownHearing Loss | OtotoxicityCanada
-
McGill University Health Centre/Research Institute...Unknown
-
Sunnybrook Health Sciences CentreRecruiting
-
CHU de Quebec-Universite LavalTerminatedHead and Neck Cancer | Adverse Effect | DDPCanada
-
Sunnybrook Health Sciences CentreLondon Regional Cancer Program, Canada; Toronto Sunnybrook Regional Cancer...RecruitingOtotoxic Hearing LossCanada
-
Astellas Pharma Europe B.V.FibroGenCompletedAnemia in Chronic Kidney Disease in Non-dialysis PatientsSpain, Belarus, Bulgaria, Hungary, Poland, Romania, Russian Federation, Serbia, Ukraine, United Kingdom, Belgium, Georgia, Italy, Colombia, Dominican Republic, Estonia, Greece, Guatemala, Panama, Peru, South Africa, Turkey
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | OtotoxicityCanada, United States, Australia
-
AmgenCompletedAnemia in Chronic Kidney Disease Patients Not on DialysisUnited States, Puerto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedSarcoma | Ovarian Cancer | Brain Tumor | Ototoxicity | Neuroblastoma | Liver Cancer | Central Nervous System Tumor | Extragonadal Germ Cell Tumor | Childhood Germ Cell TumorCanada, United States, Australia